Gallery
- Karnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)Wedding pics: Mouni Roy marries Suraj Nambiar in South Indian ceremony73rd Republic Day Parade 2022 - In Pictures
Lionel Messi has not yet thought about retirement and says age will not be a determining f
- Indian Wells: Alcaraz, Swiatek win titles
- African footballer chased and thrashed away in Kerala; reports
- Hockey India announce core probable group for men's national camp in Bhubaneswar
- Interim Budget: Large number of institutions of higher learning set up, highest ever medal tally in games reflects high confidence level, says FM
- Jyoti Chhatri eyes spot in India's squad for Hockey Olympic Qualifiers
WHO hopes 2 billion coronavirus vaccine doses by next year Last Updated : 19 Jun 2020 12:12:48 AM IST Chief scientist at the World Health Organisation (WHO) Dr Soumya Swaminathan, who is the chief scientist at the World Health Organisation (WHO) on Thursday, said that nearly 2 billion doses of the Covid-19 vaccine would be ready by the end of next year.
Addressing the media from Geneva, she said that "at the moment, we do not have a proven vaccine but if we are lucky, there will be one or two successful candidates before the end of this year" and 2 billion doses by the end of next year.Scientists still predict a safe and effective vaccine against SARS-CoV-2, the virus that causes Covid-19, could take at least 12-18 months to develop.Last month, global pharmaceutical major Pfizer said that it believes that a vaccine to prevent Covid-19 could be ready by the end of October.There are currently over 100 vaccines in various stages of trials.AstraZeneca's Covid-19 vaccine candidate developed by researchers from Oxford University will likely provide protection against the disease for one year, the British drug maker's CEO told Belgian radio station Bel RTL this week.Oxford University last month announced the start of a Phase II/III UK trial of the vaccine, named AZD1222 (formerly known as ChAdOx1 nCoV-19), in about 10,000 adult volunteers. Other late-stage trials are due to begin in a number of countries.IANS London For Latest Updates Please-
Join us on
Follow us on
172.31.16.186